Mounjaro supply in the UK: the key questions, answered plainly

The fork in the road: NHS supply or private supply?

This is the practical decision most people are actually making when they search for Mounjaro supply. Two routes exist in the UK, and they have very different entry points.

NHS supply of tirzepatide is governed by NICE technology appraisal TA1026, published in December 2024. The rollout is phased. From June 2025, adults with a BMI of 40 or above and four or more of five specified weight-related conditions (high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes) became eligible. A second cohort covering BMI 35–39.9 with four or more of the same conditions opened in June 2026. Further phases follow in 2027. Ethnic-background BMI thresholds are 2.5 kg/m² lower throughout. Even within those criteria, participation by GP practices is optional and wrap-around dietary support is required, so actual access varies by location. How tirzepatide supply works in practice is worth reading if the NHS route is your primary interest.

Private supply through a GPhC-registered online pharmacy is the other route. No referral is needed. Eligibility follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition. A prescriber reviews your consultation before anything is dispensed. It's the quicker path for most people, but it is a private cost, and the prescriber's assessment is non-negotiable.

How secure is Mounjaro's supply in the UK right now?

If you've been watching this space for a while, you'll know supply hasn't always been smooth. That's a fair frustration to carry into this.

Eli Lilly has been scaling manufacturing significantly since Mounjaro's UK launch. The UK receives supply through authorised pharmaceutical distributors; this is not a grey-market import. Periods of tighter stock have occurred, particularly at mid-range doses as more people started treatment, and a detailed breakdown of UK supply issues covers how those have played out.

From a practical standpoint: availability of individual dose strengths fluctuates, and what's in stock at any given pharmacy on any given week may not reflect the broader picture. A clinically reviewed private prescription issued by a GPhC-registered prescriber gives you access through the licensed chain. At consultation stage, confirming which doses are currently available is always the right move before planning a titration schedule around a specific pen.

It is also worth noting that Eli Lilly raised its UK list price for Mounjaro from 1 September 2025. The background on Lilly's UK price change explains what that means for private costs, because it has altered the pricing landscape noticeably.

Counterfeit supply: a genuine risk, briefly

Any discussion of Mounjaro supply in the UK has to include this. The MHRA has issued repeated public warnings about fake weight-loss pens sold online and via social media. In October 2025, enforcement teams raided the first UK manufacturing site producing counterfeit tirzepatide pens, and approximately 20 million doses of illegally traded weight-loss medicines with an estimated street value of £45 million were seized across 2025 operations.

Fake pens have contained the wrong substances; some have contained insulin. The consequences can be serious. The safe supply route is through a pharmacy you can verify on the GPhC register at the GPhC's pharmacy register. Red flags include sellers offering Mounjaro without a clinical assessment, prices far below the current market range, and discount codes attached to prescription medicines. You can report suspect sellers directly through the MHRA's Yellow Card scheme.

If you're researching who stocks genuine Mounjaro, the guidance on finding a legitimate Mounjaro supplier lays out exactly what to look for and what to avoid.

Deciding whether to pursue private supply now

The supply question and the eligibility question are connected. If you meet the private licensed criteria, a regulated pharmacy can move quickly. At nume, consultations are reviewed the same day by a GPhC-registered Independent Prescriber, ID and weight are verified, and treatment dispatched the same working day when ordered before noon, arriving by tracked DPD the next working day. There's no subscription and no auto-renewal; every repeat order is reviewed before it goes out.

For people thinking about a longer course, a three-month supply of Mounjaro is one option worth exploring, though stock and clinical suitability at each stage always need to be confirmed. The full Mounjaro overview covers the clinical picture, and our weight-loss treatment options page sets private treatment in the broader context of what's available.

One transparent price covers consultation, prescription, treatment, delivery, and aftercare seven days a week. No hidden fees. Speak to our prescribers to find out whether you're a good candidate, and which dose is available right now.

Start your free consultation with our prescribers and get a same-day clinical decision.